SARAH BLACKSTOCK: Open Payments
NPI 1598249211 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 10 payments from 7 companies in 2025. Trend: 2023 $994 · 2024 $308 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $170 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Shionogi Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
Products named: DALVANCE, NUZYRA, Fetroja, EMBLAVEO, TEFLARO, ZEVTERA, VOWST, Fluad.
Industry payments across GA — which companies pay providers there.
